[Historical considerations on La Peyronie's disease. Very little has changed!]

Journal D'Urologie
|January 1, 1984
PubMed

Insights

Peyronie's disease, a condition of the corpus cavernosum, has historical roots with early observations on its pathology and associations with diabetes. Modern understanding echoes these early insights, guiding current treatment approaches.

Area of Science:

  • Urology
  • Andrology
  • Medical History

Context:

  • Peyronie's disease, characterized by plastic induration of the corpus cavernosum, was first described in 1743.
  • Historical clinical descriptions reveal striking parallels with contemporary understanding of its pathology and etiopathogenicity.
  • Early observations noted associations with diabetes and Dupuytren's disease, dating back to 1850.

Purpose:

  • To review the historical context and evolution of understanding Peyronie's disease.
  • To highlight the enduring relevance of early clinical observations and etiological hypotheses.
  • To trace the development of treatment concepts from historical perspectives.

Summary:

  • The historical literature on Peyronie's disease shows remarkable consistency with current concepts regarding pathology and causes.
  • Inflammation followed by fibrosis was proposed as early as 1886.
  • Treatment ideas, such as contralateral plication, were suggested in 1899 to correct penile curvature.

Impact:

  • Understanding the historical trajectory of Peyronie's disease research provides valuable context for current scientific inquiry.
  • Recognizing the long-standing associations with other conditions like diabetes aids in comprehensive patient management.
  • Historical treatment concepts, though rudimentary, foreshadowed modern surgical interventions.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...